LIPAGLYN - The novel drug for treating Diabetic Dyslipidemia

These terms were last revised on 09/09/2015.

This website is maintained by Cadila Healthcare Limited. ("Zydus").

By using this website, you agree to be bound by, and to comply with, the terms of use on this page ("Terms of Use"). Cadila Healthcare Limited reserves the right to change the Terms of Use from time to time, as necessary, and will provide notice, on this page, of any such changes, including the date they became effective. You may access this page at any time through the Terms of Use link at the bottom of each page on this website.

Nothing on this website should be construed as the giving of advice or the making of a recommendation regarding any decision or action related to your health or the health of others. If you are a patient, you should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any treatment decisions. If you are a doctor or other qualified health care professional, you should not allow the content of this website to substitute for your own medical judgment, which you should exercise in evaluating the information on this website.

Except for information covered by our privacy policy, any communication or materials you transmit to or through the website, including data, comments, questions, suggestions, ideas, concepts, know-how, techniques, or the like, shall become the property of Cadila Healthcare Limited. Cadila Healthcare Limited shall be free to use, disclose, reproduce, or distribute any such communications or materials without limitation of any kind.

This website may contain information brought to you by third parties or through links to other Internet websites. Notice of information or links of this kind is provided throughout the website. Cadila Healthcare Limited does not control nor assume any responsibility for the information provided by third parties or the content of other Internet websites to which we provide links.